The Education and Information Core has two broad aims:
The first aim i s to provide educational outreach, in Spanish and English, to a culturally diverse group of lay and community professionals in order to recruit and retain ADRC subjects by publicizing clinical and research activities in the ADRC. This will be accomplished through community lectures that highlight recent research findings and AD diagnosis/treatment. Brown Bag lunch programs for caregivers, educational programs at the new community satellite. Memory Enhancement Programs, the ADRC website, newsletters, workshops, brochures, and memory screenings. Collaboration with the Clinical Core, the Alzheimer's Association, NYCARE, the Alzheimer's Disease Assistance Center, the Carers'Program, and other departments at Mount Sinai are central to the success and implementation of the Core's programs. Outcomes will be evaluated by using surveys and questionnaires to assess the needs of both the lay and professional groups and the effectiveness of the Core's programs.
The second aim i s to enhance the development of research and clinical skills for a broad range of clinical and basic science professionals including ADRC faculty, trainees, and other investigators at Mount Sinai. This will be accomplished by offering standardized training, certification, and supervision in cognitive assessment for research for those inside and outside the ADRC, translational lecture programs, the creation of a new UDS neuropsychological training video, CME programs, and didactics on topics related to dementia for medical and psychology trainees. These efforts will be accomplished through close collaboration with the Clinical Core, the Brain Institute at Mount Sinai, and the Alzheimer's Association. Outcomes will be evaluated by administering surveys that measure satisfaction and learning;results will be used to modify and plan future efforts.
To provide educational services and dissiminate information that maximizes participation in research. To grow scientific interest, knowledge, and visibility of ADRC programs and its scientists so that we can fulfill the scientific mission of the ADRC. EIC activities help identify the most important cohort of elders and minorities in an urban setting.
|Amrock, Levana G; Deiner, Stacie (2014) The implication of frailty on preoperative risk assessment. Curr Opin Anaesthesiol 27:330-5|
|Mitsis, Effie M; Bender, Heidi A; Kostakoglu, Lale et al. (2014) A consecutive case series experience with [18?F] florbetapir PET imaging in an urban dementia center: impact on quality of life, decision making, and disposition. Mol Neurodegener 9:10|
|Lunnon, Katie; Smith, Rebecca; Hannon, Eilis et al. (2014) Methylomic profiling implicates cortical deregulation of ANK1 in Alzheimer's disease. Nat Neurosci 17:1164-70|
|Dekosky, Steven T; Gandy, Sam (2014) Environmental exposures and the risk for Alzheimer disease: can we identify the smoking guns? JAMA Neurol 71:273-5|
|Roussos, Panos; Mitchell, Amanda C; Voloudakis, Georgios et al. (2014) A role for noncoding variation in schizophrenia. Cell Rep 9:1417-29|
|Ravona-Springer, Ramit; Heymann, Anthony; Schmeidler, James et al. (2014) The ApoE4 genotype modifies the relationship of long-term glycemic control with cognitive functioning in elderly with type 2 diabetes. Eur Neuropsychopharmacol 24:1303-8|
|Jun, Gyungah; Asai, Hirohide; Zeldich, Ella et al. (2014) PLXNA4 is associated with Alzheimer disease and modulates tau phosphorylation. Ann Neurol 76:379-92|
|Neugroschl, Judith; Sano, Mary; Luo, Xiaodong et al. (2014) Why They Stay: Understanding Research Participant Retention in Studies of Aging, Cognitive Impairment and Dementia. J Gerontol Geriatr Res 3:|
|Babi?, Mirjana; Svob Štrac, Dubravka; Mück-Šeler, Dorotea et al. (2014) Update on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease. Croat Med J 55:347-65|
|Greenbaum, Lior; Springer, Ramit Ravona; Lutz, Michael W et al. (2014) The TOMM40 poly-T rs10524523 variant is associated with cognitive performance among non-demented elderly with type 2 diabetes. Eur Neuropsychopharmacol 24:1492-9|
Showing the most recent 10 out of 255 publications